Gastrointestinal Bleeding Treatment Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

Gastrointestinal Bleeding Treatment Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

Gastrointestinal Bleeding refers to blood loss that occurs within the digestive organs. High prevalence of upper gastrointestinal bleeding, rise in applications of endoscopic hemostasis, and growing geriatric population are the main factors that are boosting the growth of the gastrointestinal bleeding treatment market. According to the World Health Organization (WHO), between 2015 and 2050, the proportion of the world's population over 60 years will nearly double from 12% to 22%. The increase in the number of geriatrics leads to consequences, such as a greater incidence of life-threatening diseases which sometimes related to gastrointestinal bleeding, further requiring treatment from hospitals. This boost the growth of the studied market.

However, the dearth of skilled labor is expected to restrain the growth of the global market in the forecast period.

Key Market TrendsUpper GI Tract Segment is Expected to Register a Good Growth Over the Forecast Period

By GI tract division, the market has been segmented into Upper GI Tract, and Lower GI Tract. The upper GI tract accounted for major share in the gastrointestinal bleeding treatment market and this trend is likely to continue during the forecast period. A peptic ulcer is one of the most common causes of upper GI tract bleeding and is known to have increased prevalence owing to an increase in H. pylori infection. Irrespective of any region, the peptic ulcer cases are quite common because of unhealthy diet habits by many people. As per a recent article of 2019, published in Medscape, peptic ulcer disease affects approximately 4.6 million people annually in the United States with an estimated 10% of the US population having evidence of a duodenal ulcer at some time. Other conditions also include esophageal varices, gastritis, and cancer of the esophagus or stomach. In addition, the growing geriatric population and rise in applications of endoscopic hemostasis also contribute to the growth of the demand for treatments related to upper gastrointestinal bleedings.

North America is Expected to lead the Gastrointestinal Bleeding Treatment Market

North America leads the market owing to the upsurge in the demand for advanced treatment options, and the prevalence of upper gastrointestinal bleeding. According to The National Institute of Diabetes and Digestive and Kidney Diseases, every year, upper GI bleeding accounts for about 100,000 hospitalizations in the United States. There is a large section of the population in the adult age group across many states, which have unhealthy diet habits leading to several problems associated to the upper and lower gastrointestinal tract, which may lead to bleeding if not diagnosed properly. Thus, a growing burden of such patients are being observed approaching the hospitals for better treatment particularly during the advanced stage of the disease. This drives the market of the gastrointestinal bleeding treatment

Europe and the Asia Pacific are followed next after North America owing to the presence of a diversified patient pool, and emerging economies in these regions, thus driving this market.

Competitive Landscape

The major players in the gastrointestinal bleeding treatment market include Boston Scientific Corporation, CONMED Corporation, Cook Group, ERBE Elektromedizin GmbH, Olympus Corporation, Ovesco Endoscopy AG, STERIS PLC and US Medical Innovations are providing these products across the globe.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

Companies Mentioned

Boston Scientific Corporation
CONMED Corporation
Cook Group
ERBE Elektromedizin GmbH
Olympus Corporation
Ovesco Endoscopy AG
STERIS PLC
US Medical Innovations

Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.